A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the ...

In 1970, only half of patients lived past five years. Now, at least 70 percent of U.S. cancer patients are surviving for at ...

According to a 2025 survey conducted by the Prevent Cancer Foundation, only 51% of U.S. adults 21 and older say they have had ...

A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the body. This is shown by ...

Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.” With the GSK deal validating the paradigm, in Alfa’s view, Noetik ...

GSK licenses Noetik’s AI foundation models in anchor partnership to transform cancer therapeutic research and development ...

CITCCA data demonstrate more than 40% of high-risk stage I–III colorectal patients harbor molecular residual disease at clinical landmark, detectable only with ultrasensitive ctDNA testingMORRISVILLE, ...

"Seven in 10 people now survive their cancer 5 years or more, up from only half in the mid-70s," Siegel said in a press ...

Lungevity Now Accepting Research Grant Applications To Drive Breakthroughs In Lung Cancer. Research programs fuel innovation in early detection, treatment, and health equity for lung cancer.

Biologist Eduard Batlle used to spend his weekends at his parents’ confectionery. Now he’s one of the six inventors of ...

A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...

Bhushra Ateeq, whose research has reshaped the understanding of prostate and colorectal cancer, was awarded the G. D. Birla Award for Scientific Research for 2025 on Wednesday.